General
Preferred name
DEZOCINE
Synonyms
Dezocine ()
Dalgan ()
Dozocine ()
Docozine ()
WY-16,225 ()
WY-16225 ()
P&D ID
PD009738
CAS
53648-55-8
Tags
available
drug
Approved by
FDA
Drug Status
investigational
approved
withdrawn
Drug indication
Analgesic
Pain
Max Phase
Phase 4
First approval
1989
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
10
Cayman Chemical Bioactives
ChEMBL Approved Drugs
ChEMBL Drugs
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
Withdrawn 2.0
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
24
Properties
(calculated by RDKit )
Molecular Weight
245.18
Hydrogen Bond Acceptors
2
Hydrogen Bond Donors
2
Rotatable Bonds
0
Ring Count
3
Aromatic Ring Count
1
cLogP
3.11
TPSA
46.25
Fraction CSP3
0.62
Chiral centers
3.0
Largest ring
8.0
QED
0.74
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
ATC
N02AX03
Therapeutic Class
Analgesics
Source data
